1-(tert-butylamino)-3-[2-(6-hydrazinylpyridazin-3-yl)phenoxy]propan-2-ol;dihydrochloride
-
![1-(tert-butylamino)-3-[2-(6-hydrazinylpyridazin-3-yl)phenoxy]propan-2-ol;dihydrochloride structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/511d9ea35c1a419fb8e187b2a51cb585.png "1-(tert-butylamino)-3-[2-(6-hydrazinylpyridazin-3-yl)phenoxy]propan-2-ol;dihydrochloride")
1-(tert-butylamino)-3-[2-(6-hydrazinylpyridazin-3-yl)phenoxy]propan-2-ol;dihydrochloride
structure -
-
CAS No:
73793-66-5
-
Formula:
C17H27Cl2N5O2
-
Chemical Name:
1-(tert-butylamino)-3-[2-(6-hydrazinylpyridazin-3-yl)phenoxy]propan-2-ol;dihydrochloride
-
Synonyms:
3-(2-(3-t-butylamino-2-hydroxy-propoxy)phenyl)-6-hydrazinopyridazine;Dl-3-(2-(3-t-butylamino-2-hydroxypropoxy)phenyl)-6-hydrazinopyridazine;prizidilol;prizidilol monohydrate;prizidilol monosulfate, monohydrate;SK and F 92657;SK and F-92657;SKF 92657;Prizidilol hydrochloride;Prizidilol HCl;SKF 92657;SK&F 92657;Prizidilol dihydrochloride;3-(2-(3-t-Butylamino-2-hydroxy-propoxy)phenyl)-6-hydrazinopyridazine;Dl-3-(2-(3-t-Butylamino-2-hydroxypropoxy)phenyl)-6-hydrazinopyridazine;1-(tert-Butylamino)-3-(2-(6-hydrazino-3-pyridazinyl)phenoxy)-2-propanol;3(2H)-Pyridazinone, 6-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-, hydrazone, dihydrochloride, (+-)-;6-(2-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-3(2H)-pyridazinone hydrazone dihydrochloride;73793-66-5;SCHEMBL7279085;DTXSID60979869;Q27290764;3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine dihydrochloride;1-(tert-Butylamino)-3-[2-(6-hydrazinylidene-1,6-dihydropyridazin-3-yl)phenoxy]propan-2-ol--hydrogen chloride (1/2);63642-19-3
-
CAS No:
1-(tert-butylamino)-3-[2-(6-hydrazinylpyridazin-3-yl)phenoxy]propan-2-ol;dihydrochloride Basic Attributes
404.3 g/mol
403.1541805 g/mol
Drug Information
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)|Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
3-(2-(3-t-butylamino-2-hydroxy-propoxy)phenyl)-6-hydrazinopyridazine
Computed Properties
Molecular Weight:404.3
Hydrogen Bond Donor Count:6
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:8
Exact Mass:403.1541805
Monoisotopic Mass:403.1541805
Topological Polar Surface Area:105
Heavy Atom Count:26
Complexity:363
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes
Request for Quotation